Medical Device User Fee Act Reauthorization Hearing Scheduled

The Energy and Commerce health subcommittee has scheduled a hearing on the reauthorization of the Medical Device User Fee Act on February 15, reports Healthwatch, a healthcare blog maintained by the Hill. CDRH director Jeffrey Shuren will testify at the hearing. The user fee is set to expire on September 30.

Back in May 2011, MD+DI Editor in Chief Heather Thompson wrote about the merits and limitations that MDUFMA has brought to the medical device regulatory scheme. This might be a good time to (re)read her piece and find out why MDUFMA III won't really solve FDA's review problems.